Back to results
US 11,737,992 B2Granted
Sphingosine kinase Type 1 inhibitors and uses thereof
AssigneesEnzo Therapeutics, Inc., Virginia Commonwealth University
InventorsSarah Spiegel, Robert Elliot Zipkin, Jeffrey Kroll Adams
Life of this patent
Estimating the term…
Abstract
Provided are inhibitors of sphingosine kinase Type I that are useful in the treatment of neuropathic pain.
Claims10
A method for treating neuropathic pain in a patient, comprising:
- administering to a patient in need of treatment for neuropathic pain a compound having the formula
A method for treating neuropathic pain in a patient, comprising:
- administering to a patient in need of treatment for neuropathic pain a compound having the formula
- wherein R comprises a straight carbon chain, a branched carbon chain, a straight carbon chain comprising one or more heteroatoms, a branched carbon chain comprising one or more heteroatoms, a cyclic ring, a heterocyclic ring, an aromatic ring, a hetero-aromatic ring, or any combination of the foregoing.
A method for treating neuropathic pain in a patient, consisting essentially of:
- administering
- to the patient.
Dependencies are inferred from the claim text.